Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1159/000243782

http://scihub22266oqcxt.onion/10.1159/000243782
suck pdf from google scholar
20029240!ä!20029240

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid20029240      Horm+Res 2009 ; 72 Suppl 2 (ä): 57-63
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Genetic and pathogenetic aspects of Noonan syndrome and related disorders #MMPMID20029240
  • Zenker M
  • Horm Res 2009[Dec]; 72 Suppl 2 (ä): 57-63 PMID20029240show ga
  • Noonan syndrome (NS) and the clinically overlapping disorders cardio-facio-cutaneous syndrome, LEOPARD syndrome, Costello syndrome and Neurofibromatosis-Noonan syndrome share the clinical features of short stature, the same spectrum of congenital heart defects, and a similar pattern of craniofacial anomalies. It is now known that all these disorders are caused by mutations in components of the RAS-MAPK signaling pathway. This pathway was previously known for its involvement in tumorigenesis. This article reviews the current knowledge on underlying genetic alterations and possible pathogenetic mechanisms responsible for NS and related disorders. It discusses the relationship between a group of developmental disorders and oncogenes. Potential future treatment prospects are based on the possibility of inhibiting RAS-MAPK signaling by pharmaceuticals.
  • |Body Height[MESH]
  • |Costello Syndrome/genetics/physiopathology[MESH]
  • |Female[MESH]
  • |Growth Disorders/genetics[MESH]
  • |Heart Defects, Congenital/genetics[MESH]
  • |Humans[MESH]
  • |LEOPARD Syndrome/genetics/physiopathology[MESH]
  • |Male[MESH]
  • |Mitogen-Activated Protein Kinases/genetics[MESH]
  • |Mutation[MESH]
  • |Neurofibromatoses/genetics/physiopathology[MESH]
  • |Noonan Syndrome/*genetics/*physiopathology[MESH]
  • |Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics[MESH]
  • |Proto-Oncogene Proteins B-raf/genetics[MESH]
  • |Proto-Oncogene Proteins p21(ras)/genetics[MESH]
  • |SOS1 Protein/genetics[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box